877 related articles for article (PubMed ID: 12068310)
21. Truncated soluble Nogo receptor binds Nogo-66 and blocks inhibition of axon growth by myelin.
Fournier AE; Gould GC; Liu BP; Strittmatter SM
J Neurosci; 2002 Oct; 22(20):8876-83. PubMed ID: 12388594
[TBL] [Abstract][Full Text] [Related]
22. Immunization with recombinant Nogo-66 receptor (NgR) promotes axonal regeneration and recovery of function after spinal cord injury in rats.
Yu P; Huang L; Zou J; Yu Z; Wang Y; Wang X; Xu L; Liu X; Xu XM; Lu PH
Neurobiol Dis; 2008 Dec; 32(3):535-42. PubMed ID: 18930141
[TBL] [Abstract][Full Text] [Related]
23. The Nogo-66 receptor: focusing myelin inhibition of axon regeneration.
McGee AW; Strittmatter SM
Trends Neurosci; 2003 Apr; 26(4):193-8. PubMed ID: 12689770
[TBL] [Abstract][Full Text] [Related]
24. Receptors for myelin inhibitors: Structures and therapeutic opportunities.
Cao Z; Gao Y; Deng K; Williams G; Doherty P; Walsh FS
Mol Cell Neurosci; 2010 Jan; 43(1):1-14. PubMed ID: 19619659
[TBL] [Abstract][Full Text] [Related]
25. Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury.
Li S; Liu BP; Budel S; Li M; Ji B; Walus L; Li W; Jirik A; Rabacchi S; Choi E; Worley D; Sah DW; Pepinsky B; Lee D; Relton J; Strittmatter SM
J Neurosci; 2004 Nov; 24(46):10511-20. PubMed ID: 15548666
[TBL] [Abstract][Full Text] [Related]
26. TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration.
Shao Z; Browning JL; Lee X; Scott ML; Shulga-Morskaya S; Allaire N; Thill G; Levesque M; Sah D; McCoy JM; Murray B; Jung V; Pepinsky RB; Mi S
Neuron; 2005 Feb; 45(3):353-9. PubMed ID: 15694322
[TBL] [Abstract][Full Text] [Related]
27. Oligodendrocyte myelin glycoprotein (OMgp): evolution, structure and function.
Vourc'h P; Andres C
Brain Res Brain Res Rev; 2004 May; 45(2):115-24. PubMed ID: 15145622
[TBL] [Abstract][Full Text] [Related]
28. Zinc metalloproteinase-mediated cleavage of the human Nogo-66 receptor.
Walmsley AR; McCombie G; Neumann U; Marcellin D; Hillenbrand R; Mir AK; Frentzel S
J Cell Sci; 2004 Sep; 117(Pt 19):4591-602. PubMed ID: 15331667
[TBL] [Abstract][Full Text] [Related]
29. beta1-integrin mediates myelin-associated glycoprotein signaling in neuronal growth cones.
Goh EL; Young JK; Kuwako K; Tessier-Lavigne M; He Z; Griffin JW; Ming GL
Mol Brain; 2008 Oct; 1():10. PubMed ID: 18922173
[TBL] [Abstract][Full Text] [Related]
30. Gangliosides and Nogo receptors independently mediate myelin-associated glycoprotein inhibition of neurite outgrowth in different nerve cells.
Mehta NR; Lopez PH; Vyas AA; Schnaar RL
J Biol Chem; 2007 Sep; 282(38):27875-86. PubMed ID: 17640868
[TBL] [Abstract][Full Text] [Related]
31. NgR acts as an inhibitor to axonal regeneration in adults.
Zhang S; Zhang Q; Zhang JH; Qin X
Front Biosci; 2008 Jan; 13():2030-40. PubMed ID: 17981689
[TBL] [Abstract][Full Text] [Related]
32. LDL receptor-related protein-1 is a sialic-acid-independent receptor for myelin-associated glycoprotein that functions in neurite outgrowth inhibition by MAG and CNS myelin.
Stiles TL; Dickendesher TL; Gaultier A; Fernandez-Castaneda A; Mantuano E; Giger RJ; Gonias SL
J Cell Sci; 2013 Jan; 126(Pt 1):209-20. PubMed ID: 23132925
[TBL] [Abstract][Full Text] [Related]
33. Nogo-66 receptor antagonist peptide promotes axonal regeneration.
GrandPré T; Li S; Strittmatter SM
Nature; 2002 May; 417(6888):547-51. PubMed ID: 12037567
[TBL] [Abstract][Full Text] [Related]
34. Targeting the Nogo-A signalling pathway to promote recovery following acute CNS injury.
Walmsley AR; Mir AK
Curr Pharm Des; 2007; 13(24):2470-84. PubMed ID: 17692015
[TBL] [Abstract][Full Text] [Related]
35. Versican V2 and the central inhibitory domain of Nogo-A inhibit neurite growth via p75NTR/NgR-independent pathways that converge at RhoA.
Schweigreiter R; Walmsley AR; Niederöst B; Zimmermann DR; Oertle T; Casademunt E; Frentzel S; Dechant G; Mir A; Bandtlow CE
Mol Cell Neurosci; 2004 Oct; 27(2):163-74. PubMed ID: 15485772
[TBL] [Abstract][Full Text] [Related]
36. Oligodendrocyte-myelin glycoprotein and Nogo negatively regulate activity-dependent synaptic plasticity.
Raiker SJ; Lee H; Baldwin KT; Duan Y; Shrager P; Giger RJ
J Neurosci; 2010 Sep; 30(37):12432-45. PubMed ID: 20844138
[TBL] [Abstract][Full Text] [Related]
37. Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo.
Zheng B; Atwal J; Ho C; Case L; He XL; Garcia KC; Steward O; Tessier-Lavigne M
Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1205-10. PubMed ID: 15647357
[TBL] [Abstract][Full Text] [Related]
38. Structural features of the Nogo receptor signaling complexes at the neuron/myelin interface.
Saha N; Kolev M; Nikolov DB
Neurosci Res; 2014 Oct; 87():1-7. PubMed ID: 24956133
[TBL] [Abstract][Full Text] [Related]
39. The Nogo receptor, its ligands and axonal regeneration in the spinal cord; a review.
Hunt D; Coffin RS; Anderson PN
J Neurocytol; 2002 Feb; 31(2):93-120. PubMed ID: 12815233
[TBL] [Abstract][Full Text] [Related]
40. A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors.
Park JB; Yiu G; Kaneko S; Wang J; Chang J; He XL; Garcia KC; He Z
Neuron; 2005 Feb; 45(3):345-51. PubMed ID: 15694321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
